144 related articles for article (PubMed ID: 3068803)
1. The lungs in systemic sclerosis (scleroderma): a review and new information.
McCarthy DS; Baragar FD; Dhingra S; Sigurdson M; Sutherland JB; Rigby M; Martin L
Semin Arthritis Rheum; 1988 May; 17(4):271-83. PubMed ID: 3068803
[No Abstract] [Full Text] [Related]
2. Lung involvement in systemic sclerosis.
Silver RM; Miller KS
Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
[TBL] [Abstract][Full Text] [Related]
3. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary function in patients with systemic sclerosis.
Spagnolatti L; Zoia MC; Volpini E; Convertino G; Fulgoni P; Corsico A; Vitulo P; Cerveri I
Monaldi Arch Chest Dis; 1997 Feb; 52(1):4-8. PubMed ID: 9151512
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of bronchoalveolar lavage cellular analysis in scleroderma lung disease.
Kinder BW; King TE
Am J Respir Crit Care Med; 2008 Jun; 177(11):1292-3; author reply 1293. PubMed ID: 18487622
[No Abstract] [Full Text] [Related]
6. Preliminary report: the origin of lavage neutrophils in fibrosing alveolitis associated with systemic sclerosis.
Reich JM
Sarcoidosis Vasc Diffuse Lung Dis; 1997 Sep; 14(2):189-90. PubMed ID: 9306513
[No Abstract] [Full Text] [Related]
7. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary scleroderma.
Weaver AL; Divertie MB; Titus JL
Dis Chest; 1968 Dec; 54(6):490-8. PubMed ID: 5722767
[No Abstract] [Full Text] [Related]
9. Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators.
Kowal-Bielecka O; Kowal K; Distler O; Rojewska J; Bodzenta-Lukaszyk A; Michel BA; Gay RE; Gay S; Sierakowski S
Arthritis Rheum; 2005 Dec; 52(12):3783-91. PubMed ID: 16320329
[TBL] [Abstract][Full Text] [Related]
10. High resolution computed tomography in early scleroderma lung disease.
Warrick JH; Bhalla M; Schabel SI; Silver RM
J Rheumatol; 1991 Oct; 18(10):1520-8. PubMed ID: 1765976
[TBL] [Abstract][Full Text] [Related]
11. [Diffusion disorders in patients with scleroderma].
Konietzko N; Carton RW
Beitr Klin Erforsch Tuberk Lungenkr; 1969; 139(3):196-205. PubMed ID: 5801289
[No Abstract] [Full Text] [Related]
12. [Pulmonary involvement in sclerodermia].
Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary manifestations of the collagen vascular diseases.
Wiedemann HP; Matthay RA
Clin Chest Med; 1989 Dec; 10(4):677-722. PubMed ID: 2689071
[TBL] [Abstract][Full Text] [Related]
14. Shrinking lung syndrome in systemic sclerosis.
Scirè CA; Caporali R; Zanierato M; Mojoli F; Braschi A; Montecucco C
Arthritis Rheum; 2003 Oct; 48(10):2999-3000. PubMed ID: 14558114
[No Abstract] [Full Text] [Related]
15. The lung in systemic sclerosis.
Steen VD
J Clin Rheumatol; 2005 Feb; 11(1):40-6. PubMed ID: 16357695
[No Abstract] [Full Text] [Related]
16. [Systemic scleroderma. Contribution of esophageal manometry].
Veyrac M; Meunier L; Aubin JP; Guillot B; Michel B; Bories P; Meynadier J; Michel H
Presse Med; 1986 May; 15(21):957-9. PubMed ID: 2942850
[TBL] [Abstract][Full Text] [Related]
17. [Clinical aspects of respiratory pathology in scleroderma. Case reports].
Galietti F; Giorgis GE; Ardizzi A; Oliaro A; Zampollo M; Bernardi V; Miravalle C
Minerva Med; 1990 Mar; 81(3):181-4. PubMed ID: 2320285
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary inflammation in systemic sclerosis. An assessment by bronchoalveolar lavage].
Salaffi F; Subiaco S; Carotti M; Blasetti P; Cervini C
Recenti Prog Med; 1994 Oct; 85(10):475-80. PubMed ID: 7809460
[TBL] [Abstract][Full Text] [Related]
19. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.
Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561
[TBL] [Abstract][Full Text] [Related]
20. Imaging of pulmonary disease in scleroderma with J001X scintigraphy.
Diot P; Diot E; Lemarie E; Guilmot JL; Baulieu JL; Asquier E; Valat C; Delarue A; Le Pape A
Thorax; 1994 May; 49(5):504-8. PubMed ID: 8016775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
